NUOBIKAN's stock plummeted 6.82% during intraday trading, extending a period of significant decline for the company's shares.

The sharp drop is attributed to sustained selling pressure that has persisted since the stock's inclusion in the Stock Connect program, with profit-taking by early investors showing no signs of abating. Market skepticism over the company's earnings quality continues to weigh on sentiment, despite a previous clarification from the company regarding a supplier revenue inflation incident.

Furthermore, a severe mismatch between the company's reported revenue growth of 23.7% year-over-year and a net profit increase of only 2.1% is suppressing prospects for a valuation recovery. The stock's price volatility is amplified by its limited free float of approximately 30 million shares, which results in extremely high daily turnover rates.